Keros Therapeutics Inc — Quarterly Cash Flow (NASDAQ:KROS) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Total assets 579.27 M615.89 M784.56 M757.16 M742.78 M Total liabilities 46.44 M44.33 M55.69 M50.43 M39.2 M Total equity 532.84 M571.55 M728.87 M706.73 M703.58 M Total liabilities & shareholders' equities 579.27 M615.89 M784.56 M757.16 M742.78 M Total debt ————— Net debt —————

Nachrichten

Should Investors Buy, Sell or Hold KROS Stock Ahead of Q4 Earnings?

Will Reblozyl Shine in Bristol Myers' Fourth-Quarter Results?

SRPT Stock Up 8% on Positive Long-Term Data From Elevidys Study in DMD

Keros Therapeutics vs. Dyne: Which DMD Biotech Has More Upside?

Is KROS' KER-065 the Next Breakthrough in DMD Space?

JANX Enters Global Oncology Collaboration With BMY, Stock Rises

Ionis' Dawnzera Gets EU Approval for Hereditary Angioedema

MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know

Novartis' Ianalumab Wins Breakthrough Therapy Tag for Sjogren's Disease

Axsome Therapeutics Begins Phase III Study on AXS-14 for Fibromyalgia

Will KROS Stock's Restructuring Efforts Reap Rewards for Investors?

CG Oncology Stock Rallies Nearly 32% in a Week: Here is Why